Anti-RNF13 antibodies are used in the immunodetection of the protein ring finger protein 13. In humans, the canonical protein has a reported length of 381 amino acid residues and a mass of 42.8 kDa. Its subcellular localization is in the nucleus, lysosomes, and ER. Up to 2 different isoforms have been reported for this protein. It is widely expressed across many tissue types. Post-translational modifications have been described, including ubiquitination and glycosylation. The RNF13 gene has been associated with the disease, Developmental and epileptic encephalopathy. Synonyms for this target antigen include EIEE73, RZF, E3 ubiquitin-protein ligase RNF13, RING zinc finger protein, RING-type E3 ubiquitin transferase RNF13, and DEE73. RNF13 gene orthologs have been reported in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. Some RNF13 antibodies may have been used in research and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.